Untargeted proteomics enables ultra-rapid variant prioritization in mitochondrial and other rare diseases
Daniella Helena Hock, Nikeisha J. Caruana, Liana N. Semcesen, Nicole J. Lake, Luke E. Formosa, Sumudu S. C. Amarasekera, Tegan L. Stait, Simone Tregoning, Leah E. Frajman, David R. L. Robinson, Megan Ball, Boris Reljić, Bryony Ryder, Mathew Wallis, Anand Vasudevan, , David A. Stroud
This study uses untargeted proteomics to rapidly prioritize genetic variants in mitochondrial and other rare diseases, achieving functional evidence for 83% of cases in a cohort.
medRxiv · Aug 6, 2024 · PreprintGenetic & Genomic Medicine